Vanguard Group Inc Adma Biologics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 21,363,715 shares of ADMA stock, worth $358 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,363,715
Previous 16,841,449
26.85%
Holding current value
$358 Million
Previous $334 Million
16.43%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ADMA
# of Institutions
407Shares Held
193MCall Options Held
2.13MPut Options Held
1.59M-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$215 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
-
Nuveen, LLC Charlotte, NC5.56MShares$93.2 Million0.03% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...